1-4 of 4
Laurie L. Moon-Tasson, BA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of a Novel, First-in-Class Modulator of Eukaryotic Translation Initiation Factor 5A (eIF5A) in Patients (pts) with Relapsed or Refractory B-Cell Malignancies: Data from a Phase 1-2 Study

Alice S Bexon, MD, Michael Craig, MD, David S. Siegel, MD PhD, William Bensinger, Nicolas Novitzky, MD PhD, Andrew McDonald, MBChB, Martin Gutierrez, MD, Edward N. Libby, MD, Frits van Rhee, MD PhD, Jeremy Heidel, PhD, John Thompson, Charles Barranco, Catherine A Taylor, Kathleen A. Donovan, PhD, Laurie L. Moon-Tasson, BA, Leslie J. Browne, PhD, Michael R. Kurman, MD, John A. Lust, MD PhD, Richard Dondero
Journal: Blood
Blood (2014) 124 (21): 2121.
https://doi.org/10.1182/blood.V124.21.2121.2121
Published: 2014
Journal Articles

Interplay Between IL-1, IL-6 and IL-17 in IL-1 Receptor Antagonist (IL-1Ra) Treated Multiple Myeloma Patients

Kathleen A. Donovan, PhD, Laurie L. Moon-Tasson, BA, John A Lust, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1874.
https://doi.org/10.1182/blood.V120.21.1874.1874
Published: 2012
Journal Articles

Long Term Follow-up of IL-1 Receptor Antagonist and Dexamethasone Phase II Clinical Trial in Patients with Smoldering/Indolent Myeloma Shows Improved Survival in Responsive Patients: Implications for Targeting Interleukin-1 Induced IL-6 Production and the Myeloma Proliferative Component

John A Lust, MD, PhD, Martha Q Lacy, MD, Steven R Zeldenrust, MD, PhD, Angela Dispenzieri, MD, Morie A Gertz, MD, Philip R. Greipp, MD, Thomas E. Witzig, MD, Shaji Kumar, MD, Laurie L. Moon-Tasson, BA, S. Vincent Rajkumar, MD, Kathleen A. Donovan, PhD
Journal: Blood
Blood (2011) 118 (21): 2945.
https://doi.org/10.1182/blood.V118.21.2945.2945
Published: 2011
Journal Articles

Functional P2X7 Receptors in Myeloma Cell Lines and Myeloma Patient Bone Marrow Samples Can Be Blocked by Specific P2X7 Receptor Antagonists: Implications for Myeloma Therapy and Chemotherapy Induced Inflammation.

Kathleen A. Donovan, PhD, Laurie L. Moon-Tasson, BA, Alexander E. Hromockyj, PhD, Debra M Meyer, PhD, Andrew D Stone, Michael J Lust, John A Lust, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1845.
https://doi.org/10.1182/blood.V118.21.1845.1845
Published: 2011